BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 11801548)

  • 21. Uterine cervical carcinoma: comparison of standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival.
    Hawighorst H; Knapstein PG; Knopp MV; Weikel W; Brix G; Zuna I; Schönberg SO; Essig M; Vaupel P; van Kaick G
    Cancer Res; 1998 Aug; 58(16):3598-602. PubMed ID: 9721867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
    Inoue K; Kamada M; Slaton JW; Fukata S; Yoshikawa C; Tamboli P; Dinney CP; Shuin T
    Clin Cancer Res; 2002 Jun; 8(6):1863-70. PubMed ID: 12060629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy.
    Parikh RR; Yang Q; Haffty BG
    Cancer; 2007 Feb; 109(3):566-73. PubMed ID: 17183558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytosol vascular endothelial growth factor in endometrial carcinoma: correlation with disease-free survival.
    Chen CA; Cheng WF; Lee CN; Wei LH; Chu JS; Hsieh FJ; Hsieh CY
    Gynecol Oncol; 2001 Feb; 80(2):207-12. PubMed ID: 11161861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancer.
    Bottini A; Berruti A; Bersiga A; Brizzi MP; Allevi G; Bolsi G; Aguggini S; Brunelli A; Betri E; Generali D; Scaratti L; Bertoli G; Alquati P; Dogliotti L
    Clin Cancer Res; 2002 Jun; 8(6):1816-21. PubMed ID: 12060622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer.
    McCarthy NJ; Yang X; Linnoila IR; Merino MJ; Hewitt SM; Parr AL; Paik S; Steinberg SM; Hartmann DP; Mourali N; Levine PH; Swain SM
    Clin Cancer Res; 2002 Dec; 8(12):3857-62. PubMed ID: 12473600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer.
    Kim SH; Kwon HC; Oh SY; Lee DM; Lee S; Lee JH; Roh MS; Kim DC; Park KJ; Choi HJ; Kim HJ
    Am J Clin Oncol; 2009 Feb; 32(1):38-43. PubMed ID: 19194123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
    Liu DB; Chen KN; Cao XZ; Wang T
    Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical study of dihydropyrimidine dehydrogenase (DPD) and p53 in biopsied specimens of esophageal cancer before chemoradiotherapy].
    Hisamitsu K; Fukuda K; Oka S; Yamaguchi K; Katano K; Ikeguchi M; Tsujitani S; Kaibara N
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1527-9. PubMed ID: 11707971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
    Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell cycle proteins predict recurrence in stage II and III colon cancer.
    Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic study of neovascularization and VEGF expression in superficial esophageal carcinoma.
    Fujii T; Sudo T; Sueyoshi S; Tanaka T; Fujita H; Shirouzu K; Ban S; Toyonaga A; Kato S; Yamana H
    Int J Oncol; 2002 Dec; 21(6):1181-7. PubMed ID: 12429966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.